Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.375 GBX | -2.17% | -.--% | -3.57% |
04-17 | ReNeuron Group Reports CFO Resignation | MT |
04-17 | ReNeuron CFO steps down to pursue other opportunities | AN |
Chart calendar ReNeuron Group plc
Upcoming events on ReNeuron Group plc
Past events on ReNeuron Group plc
08/11/2023 07:01 | Q2 2024 Earnings Release |
22/08/2023 09:30 | Annual General Meeting |
25/05/2023 09:30 | Q4 2023 Earnings Call |
25/05/2023 07:00 | Q4 2023 Earnings Release |
13/03/2023 | Advanced Therapies conference |
02/12/2022 07:00 | Interim 2023 Earnings Release |
03/10/2022 | Therapeutic Development Summit |
09/09/2022 09:30 | Annual General Meeting |
04/07/2022 15:00 | FY 2022 Earnings Call - Second Call |
04/07/2022 13:00 | FY 2022 Earnings Call - First Call |
04/07/2022 07:00 | FY 2022 Earnings Release |
07/05/2022 15:35 | International Society of Cell and Gene Therapy Meeting |
05/05/2022 16:45 | International Society of Cell and Gene Therapy Meeting |
04/02/2022 12:00 | Strategic Update Call |
30/11/2021 15:00 | Interim 2022 Earnings Call - Second Call |
30/11/2021 13:00 | Interim 2022 Earnings Call - First Call |
30/11/2021 07:00 | Interim 2022 Earnings Release |
16/09/2021 10:00 | Annual General Meeting |
08/07/2021 16:30 | FY 2021 Earnings Call |
08/07/2021 07:00 | FY 2021 Earnings Release |
Annual results
Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales Million GBP | Released Forecast Spread | 0,05 1,97 -97.51% | 6,17 6,30 -2.1% | 0,26 0,50 -48.19% | 0,40 0,28 46.55% | 0,53 0,64 -17.38% |
EBITDA Million GBP | Released Forecast Spread | -18,0 -21,1 14.65% | -14,0 -21,5 35.05% | -12,5 -14,1 11.24% | -10,9 -10,7 -1.82% | -6,85 0,00 - |
EBIT Million GBP | Released Forecast Spread | -18,3 -21,4 14.54% | -14,4 -20,3 28.91% | -12,9 -14,7 12.1% | -11,2 -11,7 4.12% | -7,12 -8,51 16.35% |
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -17,2 -17,7 2.72% | -13,9 -22,8 39.17% | -13,4 -14,9 9.76% | -11,1 -11,7 5.66% | -6,66 -8,24 19.21% |
Net income Million GBP | Released Forecast Spread | -14,3 -15,4 7.06% | -11,4 -19,2 40.57% | -11,3 -13,4 15.07% | 0,00 0,00 - | -5,41 -6,92 21.83% |
EPS GBP | Released Forecast Spread | -0,45 -0,49 7.13% | -0,36 -0,60 40.49% | -0,29 -0,33 11.72% | 0,00 0,00 - | -0,10 -0,12 20.5% |
Announcement Date | 11/07/19 | 20/07/20 | 08/07/21 | 04/07/22 | 25/05/23 |
Quarterly results
Fiscal Period | March | 2020 S1 | 2021 S2 |
---|---|---|---|
Net sales Million GBP | Released Forecast Spread | 0,22 1,00 -78.4% | |
EBIT Million GBP | Released Forecast Spread | -5,71 -5,11 -11.81% | 5,17 -6,70 177.22% |
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -5,14 -5,11 -0.72% | |
Net income Million GBP | Released Forecast Spread | -3,90 -5,11 23.67% | |
EPS GBP | Released Forecast Spread | -0,12 -0,16 24.54% | |
Announcement Date | 06/12/19 | 08/07/21 |
Past sector events for ReNeuron Group plc
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RENE Stock
- Calendar ReNeuron Group plc